Kayitalire Louis 4
4 · F-star Therapeutics, Inc. · Filed Nov 24, 2020
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2020-11-20+26,437→ 26,437 total→ Common Stock (26,437 underlying) - Award
Stock Option (right to buy)
2020-11-20+27,289→ 27,289 totalExercise: $16.62Exp: 2029-06-17→ Common Stock (27,289 underlying)
Footnotes (4)
- [F1]This option was issued in replacement of an option to purchase shares of F-star Therapeutics Limited.
- [F2]28% of the options shall vest on the first anniversary of the commencement of employment of the option holder and 2% on the last day of each month subsequent to such first anniversary until the option is fully vested on the fourth anniversary from commencement of employment.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F4]Twenty-five per cent (25%) of the total number of Shares under Award shall vest on the first anniversary of the Vesting Commencement Date, July 1, 2020, and two and one twelfth per cent (2.083%) of the total number of Shares under Award shall vest monthly thereafter, provided in each case that the Participant remains a Service Provider continuously from the Vesting Commencement Date to the relevant date.